Cargando…
Methylglyoxal: A Relevant Marker of Disease Activity in Patients with Rheumatoid Arthritis
BACKGROUND: The contribution of methylglyoxal (MGO) and soluble receptor for advanced glycation end products (sRAGE) in the presence of rheumatoid arthritis (RA) is still unknown. We investigated whether serum MGO and sRAGE were related to the presence of disease activity in RA. METHODS: 80 patients...
Autores principales: | Knani, Ines, Bouzidi, Hassan, Zrour, Saoussen, Bergaoui, Naceur, Hammami, Mohamed, Kerkeni, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828101/ https://www.ncbi.nlm.nih.gov/pubmed/29606988 http://dx.doi.org/10.1155/2018/8735926 |
Ejemplares similares
-
Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect
por: Haddad, Mohamed, et al.
Publicado: (2016) -
Lupus érythémateux systémique induit par l'isoniazide: une complication rare à craindre
por: Jguirim, Mahbouba, et al.
Publicado: (2015) -
Methylglyoxal modulates immune responses: relevance to diabetes
por: Price, Claire L, et al.
Publicado: (2010) -
Mitochondria as disease-relevant organelles in rheumatoid arthritis
por: Weyand, Cornelia M, et al.
Publicado: (2022) -
La tolérance de la vaccination COVID-19 chez les patients atteints de polyarthrite rhumatoïde
por: Ghali, M., et al.
Publicado: (2022)